Investment Insights: Pfizer and Algonquin's Growth Potential

This chapter delves into prudent investment strategies by examining companies with a strong margin of safety, focusing on Pfizer and Algonquin. The discussion highlights Pfizer's attractive dividend yield and low-risk profile alongside Algonquin's growth potential driven by strategic changes and reduced debt.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app